Trials / Recruiting
RecruitingNCT06933836
DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (estimated)
- Sponsor
- Barnet Dulaney Perkins Eye Centers · Network
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Detailed description
DSLT enables newly diagnosed patients to remain well controlled and off medications
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DSLT enables newly diagnosed patients to remain well controlled and off medications | DSLT enables newly diagnosed patients to remain well controlled and off medications |
Timeline
- Start date
- 2025-03-31
- Primary completion
- 2027-11-30
- Completion
- 2027-12-31
- First posted
- 2025-04-18
- Last updated
- 2025-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06933836. Inclusion in this directory is not an endorsement.